SYROS PHARMACEUTICALS, INC. Interest Expense
SYROS PHARMACEUTICALS, INC. reported Interest Expense of $1.38 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-07-31.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-07-31
- SYROS PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-06-30 was $1.38M, a 8.14% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $1.31M, a 7.40% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-12-31 was $1.33M, a 18.03% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $1.30M, a 23.98% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $5.13M, a 24.02% increase from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $4.13M, a 5.81% increase from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $3.91M, a 118.02% increase from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $1.79M, a 2388.89% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.38M 10-Q · filed 2024-07-31 | $2.69M 10-Q · filed 2024-07-31 | $4.02M derived: sum of 3 quarters · filed 2024-07-31 | $5.32M derived: sum of 4 quarters · filed 2024-07-31 |
| 2024-03-31 | $1.31M 10-Q · filed 2024-05-14 | $2.64M derived: sum of 2 quarters · filed 2024-05-14 | $3.94M derived: sum of 3 quarters · filed 2024-05-14 | $5.22M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.63M derived: sum of 2 quarters · filed 2024-03-27 | $3.91M derived: sum of 3 quarters · filed 2024-07-31 | $5.13M 10-K · filed 2024-03-27 |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-14 | $2.58M derived: sum of 2 quarters · filed 2024-07-31 | $3.80M 10-Q · filed 2023-11-14 | $4.92M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-06-30 | $1.28M 10-Q · filed 2024-07-31 | $2.50M 10-Q · filed 2024-07-31 | $3.62M derived: sum of 3 quarters · filed 2024-07-31 | $4.67M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-14 | $2.34M derived: sum of 2 quarters · filed 2024-05-14 | $3.39M derived: sum of 3 quarters · filed 2024-05-14 | $4.38M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.18M derived: sum of 2 quarters · filed 2024-03-27 | $3.16M derived: sum of 3 quarters · filed 2024-03-27 | $4.13M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.05M 10-Q · filed 2023-11-14 | $2.03M derived: sum of 2 quarters · filed 2023-11-14 | $3.01M 10-Q · filed 2023-11-14 | $3.99M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $981.00K 10-Q · filed 2023-08-08 | $1.96M 10-Q · filed 2023-08-08 | $2.94M derived: sum of 3 quarters · filed 2023-08-08 | $3.93M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $976.00K 10-Q · filed 2023-05-10 | $1.96M derived: sum of 2 quarters · filed 2023-05-10 | $2.95M derived: sum of 3 quarters · filed 2023-05-10 | $3.92M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.97M derived: sum of 2 quarters · filed 2023-03-02 | $2.94M derived: sum of 3 quarters · filed 2023-03-02 | $3.91M 10-K · filed 2023-03-02 |
| 2021-09-30 | $984.00K 10-Q · filed 2022-11-14 | $1.95M derived: sum of 2 quarters · filed 2022-11-14 | $2.92M 10-Q · filed 2022-11-14 | $3.46M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $969.00K 10-Q · filed 2022-08-09 | $1.94M 10-Q · filed 2022-08-09 | $2.48M derived: sum of 3 quarters · filed 2022-08-09 | $2.97M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $967.00K 10-Q · filed 2022-05-16 | $1.51M derived: sum of 2 quarters · filed 2022-05-16 | $2.00M derived: sum of 3 quarters · filed 2022-05-16 | $2.49M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $541.00K 10-K · filed 2021-03-04 | $1.03M derived: sum of 2 quarters · filed 2021-11-05 | $1.52M derived: sum of 3 quarters · filed 2021-11-05 | $1.79M 10-K · filed 2023-03-02 |
| 2020-09-30 | $493.00K 10-Q · filed 2021-11-05 | $980.00K derived: sum of 2 quarters · filed 2021-11-05 | $1.25M 10-Q · filed 2021-11-05 | $1.27M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $487.00K 10-Q · filed 2021-08-05 | $757.00K 10-Q · filed 2021-08-05 | $778.00K derived: sum of 3 quarters · filed 2021-08-05 | $799.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $271.00K 10-Q · filed 2021-05-06 | $291.00K derived: sum of 2 quarters · filed 2021-05-06 | $312.00K derived: sum of 3 quarters · filed 2021-05-06 | $335.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-04 | $41.00K derived: sum of 2 quarters · filed 2021-03-04 | $64.00K derived: sum of 3 quarters · filed 2021-03-04 | $72.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | $21.00K 10-K · filed 2021-03-04 | $44.00K derived: sum of 2 quarters · filed 2021-03-04 | $52.00K derived: sum of 3 quarters · filed 2021-03-04 | |
| 2019-06-30 | $23.00K 10-K · filed 2021-03-04 | $31.00K derived: sum of 2 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $8.00K 10-K · filed 2021-03-04 | |||
| 2018-12-31 | $1.00K 10-K · filed 2021-03-04 |